Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the IdyllaTM platform: a real-world two-center experience in Greece.
Michaelidou K, Karniadakis I, Pantelaion V, Koutoulaki C, Boukla E, Folinas K, Dimaras P, Papadaki MA, Koutsopoulos AV, Mavroudis D, Vourlakou C, Mavridis K, Agelaki S. Michaelidou K, et al. Among authors: koutsopoulos av. Expert Rev Mol Diagn. 2024 Jan-Feb;24(1-2):89-98. doi: 10.1080/14737159.2024.2303320. Epub 2024 Jan 11. Expert Rev Mol Diagn. 2024. PMID: 38193169
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer.
Pallis AG, Voutsina A, Kalikaki A, Souglakos J, Briasoulis E, Murray S, Koutsopoulos A, Tripaki M, Stathopoulos E, Mavroudis D, Georgoulias V. Pallis AG, et al. Br J Cancer. 2007 Dec 3;97(11):1560-6. doi: 10.1038/sj.bjc.6604068. Epub 2007 Nov 13. Br J Cancer. 2007. PMID: 18000506 Free PMC article.
Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer.
Lasithiotaki I, Tsitoura E, Koutsopoulos A, Lagoudaki E, Koutoulaki C, Pitsidianakis G, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM. Lasithiotaki I, et al. Oncotarget. 2016 Aug 11;8(68):112371-112383. doi: 10.18632/oncotarget.11222. eCollection 2017 Dec 22. Oncotarget. 2016. PMID: 29348831 Free PMC article.
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer.
Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, Mavroudis D, Agelaki S. Papadaki MA, et al. Among authors: koutsopoulos av. Cancers (Basel). 2020 Feb 6;12(2):376. doi: 10.3390/cancers12020376. Cancers (Basel). 2020. PMID: 32041353 Free PMC article.
Intrameningioma metastasis: A case-based literature review.
Papadakis BK, Vorrias E, Bräutigam K, Chochlidakis N, Koutsopoulos A, Mavroudis D, Vakis A, Tsitsipanis C. Papadakis BK, et al. J Clin Neurosci. 2021 Nov;93:168-173. doi: 10.1016/j.jocn.2021.08.028. Epub 2021 Sep 21. J Clin Neurosci. 2021. PMID: 34656242 Review.
LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer.
Lagoudaki ED, Koutsopoulos AV, Sfakianaki M, Papadaki C, Manikis GC, Voutsina A, Trypaki M, Tsakalaki E, Fiolitaki G, Hatzidaki D, Yiachnakis E, Koumaki D, Mavroudis D, Tzardi M, Stathopoulos EN, Marias K, Georgoulias V, Souglakos J. Lagoudaki ED, et al. Among authors: koutsopoulos av. Cancers (Basel). 2024 May 10;16(10):1818. doi: 10.3390/cancers16101818. Cancers (Basel). 2024. PMID: 38791897 Free PMC article.
64 results